Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer [Phase 1]
A Phase 1 trial evaluated the HDAC inhibitor vorinostat (SAHA) in combination with capecitabine (Xeloda) using a new weekly dosing regimen i…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer [NA]
A completed clinical trial evaluating dose-dense adjuvant CMF (cyclophosphamide, methotrexate, fluorouracil) regimens in women with early-st…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy [Phase 2]
This document reports the completed status of a Phase 2 neoadjuvant trial in early breast cancer comparing letrozole alone versus letrozole …
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Surgical Intervention and Physiotherapy in Breast Cancer: Effects in Scapular Kinematics, Pain and Upper Limb Function [NA]
This clinical trial update reports on the effects of surgical intervention combined with physiotherapy on scapular kinematics, pain, and upp…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes [Phase 2]
This Clinical Trial Update reports the completion of a Phase II study evaluating an all-oral combination of low-dose etoposide and capecitab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer [Phase 1, Phase 2]
This document reports the completion and posting of results from a Phase 1/2 trial evaluating the combination of sorafenib and vinorelbine i…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating a three-drug combination of gefitinib, trastuzumab, and docetax…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of adding dexmedetomidine to a modified pectoral block in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence [Phase 3]
Phase 3 trial of NeuVax (nelipepimut-S) to prevent breast cancer recurrence in patients with low-to-intermediate HER2 expression has complet…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Phase 3]
Phase 3 trial evaluating safety and rheumatologic tolerability of letrozole in postmenopausal women with hormone receptor-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy [Phase 4]
A Phase 4 trial evaluates the efficacy of transdermal fentanyl patches for acute postoperative pain relief after mastectomy in women with br…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women [Phase 4]
Phase 4 clinical trial update showing completion of a study evaluating letrozole in postmenopausal women with locally advanced breast cancer…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer [Phase 2]
A phase 2 trial evaluated chemotherapy with or without trastuzumab, followed by autologous stem cell transplantation and radiation therapy, …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment [Phase 2]
Phase 2 study evaluating the safety and efficacy of letrozole monotherapy as second-line endocrine therapy in postmenopausal women with adva…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update evaluating efficacy and safety of everolimus in postmenopausal women with estrogen receptor–positive locally advanced o…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating pixantrone dimaleate for HER2-negative metastatic breast cancer has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE) [Phase 3]
Phase 3 trial comparing T-DM1 plus pertuzumab vs trastuzumab plus a taxane in metastatic breast cancer completed with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Ruxolitinib in Patients With Breast Cancer [Phase 2]
A Phase 2 trial of ruxolitinib in patients with breast cancer was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight [Phase 2]
Phase 2 completed trial from Duke University evaluating whether exercise and dietary counseling improve physical activity, nutrition, and qu…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study of Breast Cancer Prevention by Letrozole in High Risk Women [Phase 2]
Phase 2 trial update on letrozole for breast cancer prevention in high-risk women, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Quality of Life in Breast Cancer Patients and Survivors
This ClinicalTrials.gov update reports quality-of-life outcomes from a completed study of breast cancer patients and survivors.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases [Phase 4]
Phase 4 clinical trial update assessing pain and quality of life in breast and prostate cancer patients with bone metastases.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Phase 3]
Phase 3 clinical trial update evaluating letrozole as early adjuvant therapy for postmenopausal patients with primary breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer [Phase 2]
A Phase 2 trial of paclitaxel plus bevacizumab for older patients with breast cancer has been terminated.